Claire E. Miller
No Rating Available
(Learn About Our Rating System)

Claire E. Miller, MD, MSCS

Languages spoken: English

Clinical Locations

Primary Children's Hospital

Pediatric Hematology/Oncology
Salt Lake City

  • Dr. Fraley received her medical degree from the University of New Mexico School of Medicine, followed by a Pediatrics residency at Oregon Health & Science University. She then completed a Pediatric Hematology, Oncology, and Bone Marrow Transplant fellowship at Children’s Hospital Colorado where she received additional training in clinical research through the Masters of Clinical Science program at the University of Colorado Anschutz Medical Campus. Dr. Fraley was an Instructor of Pediatrics for an additional year at Children’s Hospital Colorado, where she continued to care for patients while also developing a program of research studying neurocognitive outcomes in children with cancer and blood disorders.

    Dr. Fraley is currently an Assistant Professor of Pediatrics at the University of Utah and is in the Division of Pediatric Hematology Oncology. Clinically, she cares for patients with leukemia and lymphoma as well as long term survivors of all cancers. Dr. Fraley’s program of research examines neurocognitive dysfunction (i.e., difficulties with thinking, learning, and remembering) in childhood cancer survivors, including risk factors for dysfunction, the consequences of dysfunction, and interventions to prevent decline.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

  • Dr. Fraley received her medical degree from the University of New Mexico School of Medicine, followed by a Pediatrics residency at Oregon Health & Science University. She then completed a Pediatric Hematology, Oncology, and Bone Marrow Transplant fellowship at Children’s Hospital Colorado where she received additional training in clinical research through the Masters of Clinical Science program at the University of Colorado Anschutz Medical Campus. Dr. Fraley was an Instructor of Pediatrics for an additional year at Children’s Hospital Colorado, where she continued to care for patients while also developing a program of research studying neurocognitive outcomes in children with cancer and blood disorders.

    Dr. Fraley is currently an Assistant Professor of Pediatrics at the University of Utah and is in the Division of Pediatric Hematology Oncology. Clinically, she cares for patients with leukemia and lymphoma as well as long term survivors of all cancers. Dr. Fraley’s program of research examines neurocognitive dysfunction (i.e., difficulties with thinking, learning, and remembering) in childhood cancer survivors, including risk factors for dysfunction, the consequences of dysfunction, and interventions to prevent decline.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Hematology/Oncology
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

    Education history

    Graduate Training Clinical Science - University of Colorado Anschutz Medical Campus MSCS
    Pediatric Hematology, Oncology, & Bone Marrow Transplant - Children’s Hospital Colorado Fellow
    Residency Pediatrics - Oregon Health & Science University Resident
    Medicine - University of New Mexico School of Medicine M.D.
    Undergraduate Psychology - Vanderbilt University College of Arts and Sciences B.A.

    Selected Publications

    Journal Article

    1. Fraley CE, McKinney CM, Nuss R, Franklin ARK (2022). Minimizing Acute Toxicity and Late Effects in the Treatment of Hodgkin Lymphoma in Patients with Sickle Cell Disease. Blood Adv. (Read full article)
    2. Fraley CE, Neiman JS, Feddersen CR, James C, Jones TG, Mikkelsen M, Nuss R, Schlenz AM, Winters AC, Green AL, Compas BE (2022). Identifying Patterns of Neurocognitive Dysfunction Through Direct Comparison of Children with Leukemia, CNS Tumors, & Sickle Cell Disease. Pediatr Blood Cancer, 70(3), e30299.
    3. Fraley CE, Thigpen JC, Pearson MM, Kuttesch JF Jr, Desjardins L, Hoskinson KR, Alvarado-Gonzalez A, Esbenshade AJ, Pastakia D, Friedman DL, Wellons JC, McNally CM, Siciliano RE, Compas BE (2019). Predictors of cognitive function in pediatric brain tumor patients: Pre-surgery through 24-month follow-up. Appl Neuropsychol Child, 10(4), 340-347. (Read full article)
    4. Desjardins L, Thigpen JC, Kobritz M, Bettis AH, Gruhn MA, Ichinose M, Hoskinson K, Fraley C, Vreeland A, McNally C, Compas BE (2017). Parent reports of children's working memory, coping, and emotional/behavioral adjustment in pediatric brain tumor patients: A pilot study. Child Neuropsychol, 24(7), 959-974. (Read full article)
    5. Thigpen JC, Pearson M, Robinson KE, Andreotti C, Dunbar JP, Watson KH, Dejardins L, Holmes L, Byram R, Fraley C, Compas BE (2016). Presurgical assessment of cognitive function in pediatric brain tumor patients: feasibility and initial findings. Neurooncol Pract, 3(4), 261-267. (Read full article)

    Review

    1. Fraley C, Milgrom SA, Kondapalli L, Taylor MRG, Mestroni L, Miyamoto SD (2021). Mechanisms and Insights for the Development of Heart Failure Associated with Cancer Therapy. [Review]. Children (Basel), 8(9). (Read full article)
    2. Fraley CE, Pettersson DR, Nolt D (2021). Encephalitis in Previously Healthy Children. [Review]. Pediatr Rev, 42(2), 68-77. (Read full article)
    3. Robinson KE, Fraley CE, Pearson MM, Kuttesch JF Jr, Compas BE (2012). Neurocognitive late effects of pediatric brain tumors of the posterior fossa: a quantitative review. [Review]. J Int Neuropsychol Soc, 19(1), 44-53. (Read full article)